JEVTANA
JEVTANA
Discontinued
DIN Number
02369524
Drug Class
Human
Market Date
Aug 23, 2011
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02369524
AIG Number0152936001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CD04 CABAZITAXEL
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CABAZITAXELActive
Strength: 40 MG / ML
Monograph: CABAZITAXEL